Home > Quotes > CHRS

Coherus BioSciences, Inc. Common Stock Quote & Summary Data

Get CHRS Alerts
*Delayed - data as of Apr. 29, 2016  -  Find a broker to begin trading CHRS now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
Basic Chart Interactive Chart
Company Headlines Press Releases Market Stream
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Coherus BioSciences, Inc. Common Stock Intraday Chart

News for CHRS

Shares Traded

Trading Range

Intraday Last 52 Weeks
High $ 19.215 $ 38.10
Low $ 18.40 $ 12.04

The current last sale of $18.83 is 56.40% Higher thanthe 52 week low.

P/E Ratio

Company Description (as filed with the SEC)

We are a late-stage clinical biologics platform company focused on the global biosimilar market. Biosimilars are an emerging class of protein-based therapeutics with high similarity to approved originator products on the basis of various physicochemical and structural properties, as well as in terms of safety, purity and potency. Our goal is to become a global leader in the biosimilar market by leveraging our team's collective expertise in key areas such as process science, analytical characterization, protein production and clinical-regulatory development. Since our founding in 2010, we have advanced three product candidates into Phase 3 or Biologics License Application (BLA), enabling clinical development and entered into partnerships with two global pharmaceutical companies and one strategic biologics manufacturer.  ... More ...  

Risk Grade

Where does CHRS fit in the risk graph?

Risk Grade Scale

Nasdaq Official Price

Consensus Recommendation

Research Brokers before you trade

Want to trade FX?